Alphanate: payments to doctors
Payments that named Alphanate as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $36K
- Providers
- 77
- Transactions
- 136
- Average per transaction
- $262
The per-transaction average — $262 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 77 providers the average total is $463, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Grifols Shared Services North America, Inc. | $22,876 | 64.1% |
| Grifols Therapeutics LLC | $8,543 | 24.0% |
| Grifols USA, LLC | $4,242 | 11.9% |